CORT Earnings Date 2026
Corcept Therapeutics Incorporated earnings schedule and quarterly results
Next Earnings Date
TBD
Current Stock Price
$113.26
-0.11% today
Earnings Metrics
EPS (TTM)
$0.87
P/E Ratio
41.8
Revenue Growth
13.7%
Market Cap
$7.5B
Earnings History
| Quarter | EPS | Revenue | Net Income |
|---|---|---|---|
| Q4 2024 | $1.35 | $0.68B | $0.14B |
| Q4 2023 | $1.02 | $0.48B | $0.11B |
Trading Around CORT Earnings
Before Earnings
- Review analyst expectations and consensus estimates
- Check options implied volatility for expected move
- Consider historical earnings surprises
- Monitor pre-announcement guidance
After Earnings
- Compare actual results to estimates
- Listen to the earnings call for guidance
- Watch for analyst rating changes
- Monitor institutional buying/selling
Get Full CORT Analysis
DCF valuation, AI insights, and institutional ownership data
Frequently Asked Questions
When is CORT next earnings date?
CORT (Corcept Therapeutics Incorporated) has not yet announced its next earnings date. Check back for updates on the upcoming earnings schedule.
What is CORT earnings per share (EPS)?
CORT's current earnings per share (EPS) is $0.87. With a P/E ratio of 41.8, the market values each dollar of earnings at $41.8.
How often does CORT report earnings?
Like most publicly traded US companies, CORT (Corcept Therapeutics Incorporated) reports earnings quarterly, typically within 4-6 weeks after each fiscal quarter ends. The company holds an earnings call to discuss results with analysts.
What time does CORT report earnings?
CORT typically reports earnings either before market open (BMO) or after market close (AMC). The exact time is usually announced a few days before the earnings date. Check the investor relations page for specific timing.
How has CORT performed in recent earnings?
In the most recent quarter (Q4 2024), CORT reported EPS of $1.35 on revenue of $0.68B.
What do analysts expect for CORT earnings?
Analyst expectations for CORT earnings can vary. The company has shown positive revenue growth of 13.7%. View the full analyst ratings page for detailed expectations.